Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents
Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents
复制标题
DOI：
10.1111/j.1365-2141.2012.09187.x
复制
发表时间：
2012-09
影响因子：
6.5
通讯作者：
J. Sonnemann;B. Gruhn;S. Wittig;S. Becker;J. Beck
中科院分区：
文献类型：
--
作者：
J. Sonnemann;B. Gruhn;S. Wittig;S. Becker;J. Beck
Butterfield，Y.，Birol，I.，Holt，R.，Schein，J.，Horsman，D.E.，Moore，R.，Jones，S.J.，Connors，J.M.，Hirst，M.，Gascoyne，R.D.&Marra，M.A.(2011)非霍奇金淋巴瘤中组蛋白修饰基因的频繁突变。自然，476,298-303。非政府组织，V.N.，Young，R.M.，Schmitz，R.，Jhavar，S.，肖，W.，Lim，K.H.，KohlHammer，H.，Xu，W.，Yang，Y.，赵，H.，Shaffer，A.L.，Romesser，P.，Wright，G.，Powell，J.，Rosenwald，A.，MullerHermelink，H.K.，Ott，G.，Gascoyne，R.D.，Connors，J.M.，Rimsza，L.M.，Campo，E.，Jaffe，E.S.，Delabie，J，Smeland，E.B.，Fisher，RI.，Brasier，R.M.，Tubbs，R.R.，Cook，J.R.，Weisenburger，D.D.，Chan，W.C.&Staudt，L.M.(2011)人类淋巴瘤的致癌活性MYD88突变。大自然，470,115-119。Rinaldi，A.，Mian，M.，Chgrinova，E.，Arcaini，L.，Bhagat，G.，Novak，U.S.，Rancoita，P.M.，de Campos，C.P.，Forconi，F.，Gascoyne，R.D.，Facchetti，F.，Ponzoni，M.，Govi，S.，Ferreri，A.J.，Mollejo，M.，Piris，M.A.，Baldini，L.，Soulier，J.，Thieblemont，C.，Canzonieri，V.，Gattei，V.，Marasca，R.，Franceschetti，S.，Gaidano，G.，A.J.Tucci，A.，Uccella，S.，Tibiletti，M.G.，Dirnhofer，S.，Tripodo，C.，Dogillii，C.，Dalla Fvera，R.，Cavalli，F.，Zucca，E.，Kwee，I.&Bertoni，F.(2011)边缘地带淋巴瘤的全基因组DNA图谱分析确定了对临床结果有影响的亚型特异性病变。血液，117,1595-1604。王，L.，劳伦斯，M.S.，万，Y.，Stojanov，P.，Sougnez，C.，Stevenson，K.，Werner，L.，Sivachenko，A.，DeLuca，D.S.，Zhang，L.，Zhang，W.，Vartanov，A.R.，Fernandes，S.M.，Goldstein，N.R.，Folco，E.G.，CiBulskis，K.，Tesar，B.，Siever，Q.L.，Shefler，E.，Gabriel，S.，Haco hen，N.，Reed，R.，Meyerson，M.，Golub，T.R.，Lander，E.S.，Neuberg，D.，Brown，J.R.，Getz，G.&Wu，C.J.(2011)SF3B1和其他新的癌症基因在慢性淋巴细胞白血病中的作用。《新英格兰医学杂志》，365,2497-2506。经全基因组测序发现，MYD88(L265P)的一个体细胞变异体与淋巴浆细胞性淋巴瘤相鉴别。《血液》(ASH年会摘要)，118,261。严勇，黄勇，Watkins，A.J.，Kocialkowski，S.，Zeng，N.，Hamoudi，R.A.，Isaacson，P.G.，De Leval，L.，Wtherspoon，A.&Du，M.Q.(2012)BCR和TLR信号通路经常被脾边缘区淋巴瘤的基因变化作为靶点。血液病，97,595-598。
Butterfield, Y., Birol, I., Holt, R., Schein, J., Horsman, D.E., Moore, R., Jones, S.J., Connors, J.M., Hirst, M., Gascoyne, R.D. & Marra, M.A. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476, 298–303. Ngo, V.N., Young, R.M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., Shaffer, A.L., Romesser, P., Wright, G., Powell, J., Rosenwald, A., MullerHermelink, H.K., Ott, G., Gascoyne, R.D., Connors, J.M., Rimsza, L.M., Campo, E., Jaffe, E.S., Delabie, J., Smeland, E.B., Fisher, R.I., Braziel, R.M., Tubbs, R.R., Cook, J.R., Weisenburger, D. D., Chan, W.C. & Staudt, L.M. (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature, 470, 115–119. Rinaldi, A., Mian, M., Chigrinova, E., Arcaini, L., Bhagat, G., Novak, U., Rancoita, P.M., De Campos, C.P., Forconi, F., Gascoyne, R.D., Facchetti, F., Ponzoni, M., Govi, S., Ferreri, A.J., Mollejo, M., Piris, M.A., Baldini, L., Soulier, J., Thieblemont, C., Canzonieri, V., Gattei, V., Marasca, R., Franceschetti, S., Gaidano, G., Tucci, A., Uccella, S., Tibiletti, M.G., Dirnhofer, S., Tripodo, C., Doglioni, C., Dalla Favera, R., Cavalli, F., Zucca, E., Kwee, I. & Bertoni, F. (2011) Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117, 1595–1604. Wang, L., Lawrence, M.S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D.S., Zhang, L., Zhang, W., Vartanov, A.R., Fernandes, S.M., Goldstein, N.R., Folco, E.G., Cibulskis, K., Tesar, B., Sievers, Q.L., Shefler, E., Gabriel, S., Hacohen, N., Reed, R., Meyerson, M., Golub, T.R., Lander, E. S., Neuberg, D., Brown, J.R., Getz, G. & Wu, C. J. (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. New England Journal of Medicine, 365, 2497–2506. Xu, L., Sohani, A.R., Arcaini, L., Hunter, Z., Yang, G., Zhou, Y., Liu, X., Cao, Y., Manning, R., Patterson, C.J., Ioakimidis, L., Tripsas, C., Pinkus, G.S., Harris, N.L., Rodig, S.J. & Treon, S. (2011) A somatic variant in MYD88 (L265P) revealed by whole genome sequencing differentiates lymphoplasmacytic lymphoma from marginal zone lymphomas. Blood (ASH Annual Meeting Abstracts), 118, 261. Yan, Y., Huang, Y., Watkins, A.J., Kocialkowski, S., Zeng, N., Hamoudi, R.A., Isaacson, P.G., de Leval, L., Wotherspoon, A. & Du, M.Q. (2012) BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica, 97, 595–598.